{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699994742729472.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.cytogfr.2004.09.002"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1359610104000760?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1359610104000760?httpAccept=text/plain"}}],"dc:title":[{"@value":"The role of ephrins and Eph receptors in cancer"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699994742729474","@type":"Researcher","foaf:name":[{"@value":"Hanna Surawska"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994742729473","@type":"Researcher","foaf:name":[{"@value":"Patrick C. Ma"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994742729472","@type":"Researcher","foaf:name":[{"@value":"Ravi Salgia"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13596101"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/13596101"}],"prism:publicationName":[{"@value":"Cytokine & Growth Factor Reviews"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2004-12","prism:volume":"15","prism:number":"6","prism:startingPage":"419","prism:endingPage":"433"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1359610104000760?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1359610104000760?httpAccept=text/plain"}],"createdAt":"2004-11-06","modifiedAt":"2021-06-27","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050567175332644992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1050587981431965184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002215888475776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cell Extrusion: A Stress-Responsive Force for Good or Evil in Epithelial Homeostasis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692585656704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of Eph/ephrin tyrosine kinase in malignant glioma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711346424192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184448977536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"EphA2 Engages Git1 to Suppress Arf6 Activity Modulating Epithelial Cell–Cell Contacts"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092405582080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657488345856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658410878464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658908021760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"EphrinA1-EphA2 Signal Induces Compaction and Polarization of Madin-Darby Canine Kidney Cells by Inactivating Ezrin through Negative Regulation of RhoA"}]},{"@id":"https://cir.nii.ac.jp/crid/1390570475140486784","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"EFNB1 mutation at the ephrin ligand-receptor dimerization interface in a patient with craniofrontonasal syndrome"},{"@value":"<i>EFNB1</i> mutation at the ephrin ligand‐receptor dimerization interface in a patient with craniofrontonasal syndrome"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.cytogfr.2004.09.002"},{"@type":"CROSSREF","@value":"10.1038/s41467-020-15198-9_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1093/neuonc/nor102_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1016/j.devcel.2018.01.009_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1111/j.1741-4520.2006.00140.x_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1091/mbc.e08-06-0549_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1016/j.yexcr.2011.05.014_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1007/978-3-030-30651-9_8_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1158/1535-7163.mct-07-2263_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1007/978-94-007-4719-7_8_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1038/s41598-017-11389-5_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.1074/jbc.m111.267047_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.5729_references_DOI_DC0qWOD15uEEQG9ukFJanZg9l5o"}]}